The RAG1/RAG2 endonuclease (RAG) initiates the V(D)J recombination reaction that assembles immunoglobulin heavy (IgH) and light (IgL) chain variable region exons from germline gene segments to generate primary antibody repertoires. IgH V(D)J assembly occurs in progenitor (pro-) B cells followed by that of IgL in precursor (pre-) B cells. Expression of IgH μ and IgL (Igκ or Igλ) chains generates IgM, which is expressed on immature B cells as the B-cell antigen-binding receptor (BCR). Rag expression can continue in immature B cells, allowing continued Igκ V(D)J recombination that replaces the initial VκJκ exon with one that generates a new specificity. This 'receptor editing' process, which can also lead to Igλ V(D)J recombination and expression, provides a mechanism whereby antigen encounter at the Rag-expressing immature B-cell stage helps shape pre-immune BCR repertoires. As the major site of postnatal B-cell development, the bone marrow is the principal location of primary immunoglobulin repertoire diversification in mice. Here we report that early B-cell development also occurs within the mouse intestinal lamina propria (LP), where the associated V(D)J recombination/receptor editing processes modulate primary LP immunoglobulin repertoires. At weanling age in normally housed mice, the LP contains a population of Rag-expressing B-lineage cells that harbour intermediates indicative of ongoing V(D)J recombination and which contain cells with pro-B, pre-B and editing phenotypes. Consistent with LP-specific receptor editing, Rag-expressing LP B-lineage cells have similar VH repertoires, but significantly different Vκ repertoires, compared to those of Rag2-expressing bone marrow counterparts. Moreover, colonization of germ-free mice leads to an increased ratio of Igλ-expressing versus Igκ-expressing B cells specifically in the LP. We conclude that B-cell development occurs in the intestinal mucosa, where it is regulated by extracellular signals from commensal microbes that influence gut immunoglobulin repertoires.
The RAG1/RAG2 endonuclease (RAG) initiates the V(D)J recombination reaction that assembles immunoglobulin heavy (IgH) and light (IgL) chain variable region exons from germline gene segments to generate primary antibody repertoires. IgH V(D)J assembly occurs in progenitor (pro-) B cells followed by that of IgL in precursor (pre-) B cells. Expression of IgH μ and IgL (Igκ or Igλ) chains generates IgM, which is expressed on immature B cells as the B-cell antigen-binding receptor (BCR). Rag expression can continue in immature B cells, allowing continued Igκ V(D)J recombination that replaces the initial VκJκ exon with one that generates a new specificity. This 'receptor editing' process, which can also lead to Igλ V(D)J recombination and expression, provides a mechanism whereby antigen encounter at the Rag-expressing immature B-cell stage helps shape pre-immune BCR repertoires. As the major site of postnatal B-cell development, the bone marrow is the principal location of primary immunoglobulin repertoire diversification in mice. Here we report that early B-cell development also occurs within the mouse intestinal lamina propria (LP), where the associated V(D)J recombination/receptor editing processes modulate primary LP immunoglobulin repertoires. At weanling age in normally housed mice, the LP contains a population of Rag-expressing B-lineage cells that harbour intermediates indicative of ongoing V(D)J recombination and which contain cells with pro-B, pre-B and editing phenotypes. Consistent with LP-specific receptor editing, Rag-expressing LP B-lineage cells have similar VH repertoires, but significantly different Vκ repertoires, compared to those of Rag2-expressing bone marrow counterparts. Moreover, colonization of germ-free mice leads to an increased ratio of Igλ-expressing versus Igκ-expressing B cells specifically in the LP. We conclude that B-cell development occurs in the intestinal mucosa, where it is regulated by extracellular signals from commensal microbes that influence gut immunoglobulin repertoires.
Pre-immune Ig diversification occurs within the gut or gut
associated structures in several vertebrate species, including sheep, rabbits, cattle,
pigs and chicken[8-10]. In these species, cells harboring a
limited RAG-mediated V(D)J repertoire migrate to gut-associated structures to undergo
further diversification through somatic mutation and/or gene conversion to generate a
full pre-immune Ig repertoire[11]. These
examples raise the notion that the gut environment may provide some benefit to the
process of primary Ig diversification. In this regard, commensal
bacteria are required for primary antibody repertoire diversification in pigs and
rabbits[8,12], and may play an important role in stimulating this
process in cattle, sheep and chickens shortly after birth[11]. In contrast to the above species, RAG-mediated V(D)J
recombination is the major driver of pre-immune diversification in mice and humans. In
this context, stimulated by our prior finding of mouse B-lineage tumors that arise in
mesenteric lymph nodes from apparent receptor-editing B cells[13,14], we
hypothesized that B cell development might occur in the mouse gut and, thereby, allow
Rag expression to diversify gut B cell pre-immune repertoires.To test for RAG expression, we used our Rag2 reporter mice,
which contain a functional Rag2-Gfp fusion gene within the endogenous
Rag2 locus that provides Rag2 expression
functionally equivalent to that of the endogenous Rag2 gene[15,16]. We employed flow cytometry to test for RAG2-GFP in lymphocytes
from mesenteric lymph nodes (mLN), small intestinal (SI) lamina propria (LP), and
intraepithelial lymphocytes (IEL) of 3 wk-old mice. Cells were gated on the CD19 pan-B
lineage marker, and GFP was plotted against the B220 pan-B lineage marker. Staining with
dual B cell markers was done to optimize true GFP signal over background
auto-fluorescence, which in wild-type controls was approximately 0.1% (Fig. 1a). With this method, we found essentially no
Rag2-expressing B lineage cells in the IEL and mLN (Fig. 1a). However, we did find a population of
Rag2-expressing, CD19+ B220low cells within
the LP that comprised approximately 3% of total CD19+ cells (Fig. 1a). Quantitative PCR revealed
Rag1 and Rag2 expression in wild type small
intestinal LP at a level of about 1–10% that of total bone marrow (BM),
but little or no Rag1 or Rag2 expression in mLN or IEL
cells (Supplementary Fig. 1),
confirming the flow cytometry results found with the Rag2-Gfp reporter
mice. Large intestinal LP contained GFP+ B lineage cells as well, but at a
lower level compared to that in the SI LP (Supplementary Fig. 2). We did not find RAG2-GFP in Peyer’s
patch B cells (Supplementary Fig.
3) or mucosal T cells (Supplementary Fig. 4).
Figure 1
Gut LP RAG2+ B Lineage Cells in Weanling Age Mice
a, FACS plots of CD19+ cells from the indicated
tissues taken from wild type (WT) (top) or homozygous Rag2-Gfp
knock-in (bottom) mice. B220 expression is plotted against GFP fluorescence.
Numbers denote percentage of CD19+ B220low
RAG2-GFP+ cells. b–d, dot plots showing
percentage of RAG2-GFP+ cells in listed tissues from indicated
post-natal ages. Each point represents one mouse. Horizontal bars indicate mean
values ± s.e.m. e, Immunohistochemistry of
paraffin-embedded sections from bone marrow (BM) and small intestine (SI)
stained with an anti-TdT antibody. Dark brown indicates TdT-reactivity.
We examined various stages of early post-natal development to determine if levels
of RAG2+ B lineage cells in the gut LP change over time. The proportion of LP
RAG2-GFP+ cells among total CD19+ cells was low
(<0.5%) in the first week of life; however, after that it gradually
increased with levels peaking at approximately 4% at age 18–23 days
before decreasing to undetectable levels by post-natal day 35 (Fig. 1b). In contrast, the CD19+ B cell population of
peripheral blood contained 20–40% RAG2-GFP+ cells during the
first week of life, which then decreased over time to undetectable levels over the next
4 weeks (Fig. 1c). Similarly, RAG2-GFP+
cell levels in the spleen appeared highest (10–15%) in the first week of
life before decreasing to undetectable levels (Fig.
1d). The finding of low (<0.5%) levels of
RAG2-GFP+ cells in the gut LP in the first week of life, despite the
presence of substantial proportions of RAG2-GFP+ cells in the peripheral
blood and spleen suggests that the mechanism responsible for the later emergence of
RAG2+ cells in the gut may not be due to non-specific dissemination
driven by high levels of these cells in the blood. As RAG2+ LP B lineage
cells do not express proteins known to promote gut lymphocyte tropism such as the
α4β7 integrin or the CCR9 chemokine receptor (Supplementary Fig. 5), mechanisms
underlying their appearance in the gut remain to be determined.Sixteen days following intraperitoneal (i.p.) alum injection,
RAG2-GFP+ cells accumulate in the peripheral blood and spleens of adult
mice due to increased bone marrow output following initial alum-mediated bone marrow
suppression[17,18]. To determine if the gut LP in adult mice maintains
ability to support RAG2+ B lineage cells, we injected 4–6 month-old
Rag2-Gfp mice with i.p. alum and examined gut tissues on day 16.
Following alum injection, low levels of RAG2-GFP+ B lineage cells appeared in
IEL, mLN and PP; however, the most striking accumulation was in the LP, where
RAG2-GFP+ cells made up about 2.5% of total CD19+
cells (Supplementary Fig. 6a,
b). Appearance of RAG+ B lineage cells in the spleen and blood
following alum injection is mediated by tumor necrosis factor alpha
(TNFα)[19]. To determine
whether appearance of RAG+ B lineage cells in the small intestinal LP at
weaning age is also TNFα-dependent, we measured LP Rag1 and
Rag2 expression by qPCR in 3 wk-old Tnfα
knock-out and WT control mice and found no differences (Supplementary Fig. 6c, d). Thus,
the mechanism of gut LP RAG+ B lineage cell accumulation at weaning age
appears distinct from that of peripheral RAG+ cell accumulation that occurs
after alum immunization.RAG-expressing B lineage cells in the BM comprise a heterogeneous population of
early developmental subsets including pro-B, pre-B, and immature B cells undergoing
receptor editing[20]. The expression
patterns of Igμ and Igκ (which accounts for ~95% of
mouse IgL) can be used to distinguish these groups[5,21]. In this context,
productive assembly of Igh V(D)J exons in pro-B cells leads to the
cytoplasmic Igμ+ pre-B cell stage[21]. Assembly of Igκ VJ exons in pre-B
cells leads to formation of IgM and differentiation to the surface IgM+
immature B cell stage. Rag-expressing cells with cytoplasmic
Igκ and low or absent surface IgM have been defined as immature B cells
undergoing receptor editing[2,5,17]. Staining of fixed/permeabilized CD19+
B220low RAG2-GFP+ LP B cells for cytoplasmic Igμ and
Igκ revealed similar relative levels of pro-B cells
(Igμ−, Igκ−), pre-B cells
(Igμ+, Igκ−) and editing B cells
(Igμ+, Igκ+, RAG2+), respectively,
to those of the BM (Fig. 2a and Supplementary Fig. 7). Live
CD19+ B220low RAG2-GFP+ LP B cells that were
surface IgM+ also had similarly low IgM levels to those of this putative
editing B-lineage subset in BM (Fig. 2a and Supplementary Fig. 7). In
addition, ligation-mediated qPCR further showed that sorted RAG2-GFP+ LP B
cells had a similar level of RAG-dependent DNA double-strand breaks at
Jκ as RAG2-GFP+ BM B lineage cells (Fig. 2b), demonstrating that
Igκ V(D)J recombination takes place in the RAG2+ LP
B cells at levels similar to that in RAG2+ BM B lineage cells. Finally,
microarray analysis of RAG2+ B lineage cells in weanling age gut LP revealed
no significant differences in general transcript expression profiles in RAG2+
LP and RAG2+ BM B lineage cells (Supplementary Fig. 8), demonstrating a strong similarity between
RAG2+ cells in these two sites. Overall, these data indicate that the LP
Rag2-expressing B lineage cells contain early B lineage
developmental subsets representative of those found in the BM, supporting the occurrence
of B cell development in the LP.
Figure 2
RAG2-GFP+ LP B lineage developmental subsets
a, Plots show the relative percentage
Rag2-expressing pro-B cells, pre-B cells, editing B cells and
surface IgM+ B cells (see text for definition of each) in the bone
marrow (blue bars) and lamina propria (red bars). Plotted are mean values
± s.e.m. and each are derived from experiments of 4 independent mice at
post-natal day 17–24 (see Supplementary Fig. 7 for more details). b,
Plots show quantitative ligation-mediated PCR of RAG2+ BM B cells and
RAG2+ LP B cells normalized to genomic DNA. BM cells from
RAG2−/− mice were a negative control. Values on
the y-axis are units relative to the signal obtained from a
RAG2+ BM B cell samples.
We performed immunohistochemistry (IHC) to confirm the LP localization of early B
lineage cells in mice at post-natal day 18–23. The terminal deoxynucleotidyl
transferase (TdT) enzyme is present in pro-B cells and mediates addition of random
nucleotides to IgH V(D)J DNA ends during V(D)J recombination to
increase IgH V(D)J junctional diversity[22]. Staining for TdT, which is expressed similarly in BM
and LP RAG2+ B lineage cells (Supplementary Fig. 8), revealed a dense nuclear expression pattern
(brown) in SI LP cells similar to TdT+ cells in the bone marrow (BM) (Fig. 1e). SI sections were also subjected to dual
staining for B220 plus TdT, which showed that the TdT+ cells were also
faintly B220-positive, analogous to TdT+ cells in the BM (Supplementary Fig. 9). There were
also cells in the SI lamina propria that stained strongly for B220 but were
TdT−, representing more mature B cell populations (Supplementary Fig. 9, black
arrows). TdT+ cells were distributed throughout the LP, including within
villi; however, they generally appeared to be more proximal to bases of villi, closer to
the serosal (antiluminal) intestinal surface compared to B220high
TdT− B cells (Supplementary Fig. 10). These data indicate that gut-resident early B
lineage cells inhabit a generally distinct location within the LP compared to more
mature B cells. IHC studies of human fetal intestine also identified
serosally-positioned pre-B cells in the intestinal LP, suggesting similar early B cell
development may occur in the human gut[23].Given our finding of primary B cell development in the mouse intestinal LP, we
asked whether this process contributes to differential diversification of pre-immune
repertoires in developing RAG2+ LP B lineage cells versus those from BM. To
test this, we isolated RNA from sorted RAG2-GFP+ cells from the BM and LP
(Supplementary Fig. 11) of
3 week-old Rag2-Gfp mice, and assessed productive
V and Vκ utilization via
5’ rapid amplification of cDNA ends (5’RACE) generated from mature
Ig gene transcripts, followed by 454 sequencing. To best visualize
potential V segment utilization differences between
RAG2-GFP+ cells from LP versus BM, we plotted V segment
utilization from the two sources against individual in-frame V segments
in the order of highest to lowest utilization in RAG2-GFP+ BM cells (Fig. 3, Supplementary Fig. 12). These studies showed that
V usage was very similar in RAG2-GFP+ LP
cells and RAG2-GFP+ BM cells (χ2 test,
p=0.235) (Fig. 3a, Supplementary Fig. 12a). As a
positive control for the method, comparison of V usage
between RAG2+ BM and total non-sorted splenic B cells showed an expected
highly significant difference (χ2 test,
P=2.2×10−16) (Supplementary Figure 13a). The
similar V repertoires of RAG2+ BM and LP B
lineage cells suggests that V utilization during primary
IgH V(D)J recombination occurs similarly in the two locations. In contrast, we observed
prominent and highly significant differences in Vκ usage in
RAG2-GFP+ cells from LP versus BM (χ2 test,
P=0.00084) (Fig. 3b, Supplementary Fig. 12b); as a
negative control, we observed no significant overall differences in
Vκ usage between RAG2+ BM samples compared with
other RAG2+ BM samples; or RAG2+ LP samples compared with other
RAG2+ LP samples from separate pools of mice (χ2 test,
P=0.560 and 0.545, respectively) (Supplementary Figure 13b, c). The
finding of different Vκ repertoires within RAG2+ LP
and BM B lineage cells indicates that the LP versus BM location of B cell development
may influence Vκ usage in developing B cells. In this regard,
the very similar V repertoires of LP and BM
RAG2+ B lineage cell suggests that a likely explanation for the marked
difference in the LP Vκ repertoires from those of BM is that
they are generated in the RAG2+ receptor-editing LP B cell population.
Figure 3
Distinct Vκ segment usage in RAG2+ cells
from BM versus LP
a,b, Dot plots show contributions (in order of highest to
lowest BM utilization) of different Vs (a) and
Vκs (b) to in-frame rearrangements in
RAG2-GFP+ BM (black dots) and LP (red dots) cells. The two most
highly utilized Vs are omitted to increase plot
resolution. Each point shows mean ± s.e.m. of at least 4 experiments.
The χ2 calculated P values for overall
differences between BM and LP are indicated. Significant V
segment utilization differences between BM and LP are indicated on heat map
(P values scale indicated in inset). Full data set at
increased resolution is in Supplementary Fig. 12.
Intestinal microflora have been shown to influence immune cell development in
terms of lymphoid organization and T cell subset accumulation and activity, both locally
in the gut as well as systemically[24].
To assess influences of microflora on B cell development, we co-housed 3 week-old WT
Swiss-Webster germ-free mice with regular specific pathogen free (SPF) mice for 7 days.
Gram staining of SI contents was performed to confirm bacterial colonization of
co-housed mice (Supplementary Fig.
14). We employed qPCR to assay colonized mice and germ-free littermates for
Rag1 and Rag2 expression, which was normalized to
Cd19 expression. In accord with ability of microflora to induce
systemic effects on immune cell development[24], we observed colonization-dependent increases in
Rag1 and Rag2 expression in the BM and spleen, as
well as the gut LP (Supplementary Fig.
15). We also found pro-B cells (identified as CD19+
B220low CD43+) to represent an increased percentage of total
CD19+ B cells in colonized mouse BM and LP, and potentially in the
colonized spleen (Fig. 4a, Supplementary Fig. 16),
correspondingly, the increased Rag expression in these tissues likely
derives from the increased percentage of pro-B cells. We conclude that gut microflora
induce increased levels of pro-B cells systemically, including in the gut LP, in
previously un-colonized weaning-age mice.
Figure 4
Effects of Gut colonization on Development of LP B Lineage Cells
a, Plots of percentage of pro-B cells versus total
CD19+ B lineage cells from bone marrow (BM), spleen (SpL) and
lamina propria (LP) of 4 wk-old germfree (GF) mice and littermates colonized
(Col) by co-housing with serum pathogen free mice for 7 days. b,
Bar graphs show ratios of Igλ+ versus Igκ+
B cells within mesenteric lymph nodes (mLN), inter-epithelial lymphocyes (IEL)
and tissues indicated in (a) from GF and Col mice. Mean values and s.e.m are
shown. The P values are indicated as: *P
≤ 0.05, **P ≤ 0.01, ***P
≤ 0.001. ns = not significant. (Details in Supplementary Fig. 16 and
17)
Given our finding of different Vκ repertoires in LP
versus BM RAG2+ B lineage populations that might be generated via receptor
editing, we examined the ratio of Igλ+ to Igκ+ B
cells in the LP of colonized mice versus their germ-free mice littermates. In this
regard, increased Igλ usage in the B cell repertoire is another marker of
receptor editing[3,6,7]. Notably,
colonization led to a significant and reproducible increase of the ratio of
Igλ+ to Igκ+ B cells in the LP but not the BM
or SPL (Fig. 4b and Supplementary Fig. 17),
consistent with a commensal-dependent process leading to increased editing specifically
within LP B cells. However, as these analyses were not performed in
Rag2-Gfp mice, only total B cell populations could be analyzed.
Therefore, a non-mutually exclusive possibility would be selection for
Igλ+ B cells in the gut after colonization with commensal
microbes, a phenomenon not previously described. In this regard, we do find significant
differences in both V and Vκ
segment usage in the LP IgM+ B cell population of colonized mice compared to
germ-free littermates (Supplementary
Fig. 18), indicating presence of commensals influences both IgH and IgL
mature B cell repertoires.Consistent with growing evidence demonstrating that the microflora act as a
regulators of T lymphocyte subsets[24],
we find that weanlings harbor an intestinal LP B cell developmental process that is
influenced in germ-free mice by microbial colonization. As weaning is concurrent with
microbial expansion[25], occurrence of
Rag-expressing B lineage cell accumulation in weanlings may have
evolved to allow B cell primary repertoires to be modulated in response to colonization.
In this regard, our findings also suggest that this LP B cell developmental process
includes BCR editing, which may contribute to significant differences in the primary
Vκ repertoire of LP versus BM B lineage populations. Past
studies have implicated BCR editing in the BM as a negative selection process, largely
based on studies of B cells engineered to make specific self-reactive, high affinity
BCRs. Given the natural repertoire in our studies, the degree to which the observed BCR
editing process in the gut represents a tolerance mechanism is unclear. However, given
the potential special role of the gut in pre-immune diversification in other
vertebrates, RAG-dependent editing in the LP may also contribute diversification-related
roles. In addition, immature gut-derived B cells also may have specialized roles, such
as those suggested for immature splenic B cells[26]. Finally, primary B cell development in the intestine,
including mucosal B cell receptor editing, might allow both luminal antigens and
peripheral host mucosal components opportunities to shape the pre-immune repertoire. In
this regard, the transient nature of LP B cell development implies that there may be
windows of opportunity for this influence to occur.
METHODS
Mice, Immunizations and Colonization
Mice harboring the Rag2-Gfp knock-in fusion gene at the
endogenous locus were described previously[15] and were maintained on a 129/SvJ background. Wild type
Balb/c mice were purchased from Jackson Laboratories. Swiss-Webster germ-free
mice were purchased from Taconic Farms. For each germ-free/colonization
experiment, littermate germfree mice were used as controls. Germ-free status and
colonization status were confirmed by gram staining of cecal and small
intestinal contents as well as microbial culture. Immunization experiments were
performed with alum as described[18]. All experiments with mice followed the protocols approved
by the Boston Animal Care Facility of the Children’s Hospital, Boston,
MA 02115.
Cell Isolation and Flow Cytometry
PP, IEL and LP lymphocytes were isolated essentially as
described[27]. PPs were
excised from the small intestine, and the remaining tissue was incubated with
1×Hank’s balanced salt solution with 1 mM EDTA/10%
FBS/PBS for 30 min and room tempuratur three times for IEL extraction. Residual
intestinal tissue was digested in 20% FBSRPMI with 0.05%
collagenase from Clostridium histolyticum (Sigma) for 1 hr at 37 degrees Celsius
three times. IELs and LP cells were centrifuged over Lympholyte (Cedar Lane) per
manufacturer’s recommendations to minimize mucus contamination.
Single-cell suspensions of mLNs, PPs and spleen were prepared by mashing through
a cell strainer (70 µm). Cells were stained with fluorophore-conjugated
mouse antibodies, and flow cytometry was performed.
Real-Time qPCR and Microarray Analysis
For quantitative PCR, total RNA was extracted using the TRIzol method
(Invitrogen) and reverse transcribed into cDNA using qScript (Quanta
Biosciences). Rag1 and Rag2 transcripts were
then quantified using Taqman qPCR assays Mm01270936_m1 and Mm00501300_m1,
respectively (Applied Biosystems). The comparative Ct method was used to
quantify transcripts that were normalized with respect to Cd19
expression (Taqman assay Mm00515420_m1, Applied Biosystems). For comparative
transcriptome analysis, B cells were isolated from BM and small intestinal LP of
3 wk-old mice. Cells were sorted (BD FACSAria) into TRIzol on the basis of the
following cell surface markers: CD19+, B220low,
GFP+. RNA was extracted and then amplified, labeled, and
hybridized to Affymetrix GeneChip Mouse Gene 1.0 ST arrays (Expression Analysis,
Durham, NC). Raw data were normalized with the RMA algorithm implemented in the
Expression File Creator module from the GenePattern suite[28]. Data were visualized with the
Multiplot and Hierarchical Clustering Viewer modules. All cell populations
analyzed were generated in triplicate from independent experiments consisting of
a pool of at least 8 mice for each experiment.
Immunohistochemistry
Immunohistochemistry was performed using 4-mm-thick formalin fixed
paraffin embedded (FFPE) tissue sections. Slides were soaked in xylene, passed
through graded alcohols, and put in distilled water. Slides were pretreated with
EDTA (pH 8.0) retrieval solution (Zymed, South San Francisco, CA) in a steam
pressure cooker (Biocare Decloaking Chamber CD2008US, Biocare Biomedical,
Concord, CA) at manufacturers recommended settings. All further steps are
performed at room temperature in a hydrate chamber. The slides were blocked for
endogenous peroxidase activity with peroxidase block (DAKO), washed 5 minutes in
buffer, and followed by 20 minute incubation with serum free protein block
(DAKO). For TdT single staining, a polyclonal rabbit antibody (DAKO Cat
#A3524) was applied at 1:100 dilution for 1 hour at room temperature
followed by washing. The detection of antibody utilized DAKO Rabbit Envision and
DAB according to the manufacturer's directions. For TdT/B220 double
staining, rabbit anti-TDT was followed with Mach-2 RabbitAP polymer (Biocare)
and developed with Vulcan Fast Red (Biocare). Subsequently, rat anti-B220 (BD
Pharmingen, cat # 550286), was applied for 1 hour at 1:200 dilution
followed by Goat anti-Rat-HRP (Millipore) and developed with DAB. All slides
were counterstained with Harris hematoxylin. Stained slides were scanned at
200× magnification using an Aperio ScanScope XT workstation (Aperio
Technology, Inc., Vista, CA). Images were visualized, annotated, and microscopic
distances quantified using ImageScope software (version 10.0.35.1800, Aperio
Technology).
Ligation-mediated PCR
Sorted CD19+ B220low RAG2-GFP+ B
lineage cells from BM and LP were lysed in SDS lysis buffer (5mM EDTA, 200mM
NaCl, 100mM Tris-HCl pH 8.0, 0.2% SDS) with proteinase K (200mg/ml)
overnight at room temperature followed by incubation at 37°C for one
hour. Following DNA isolation by phenol:chloroform separation and isopropanol
precipitation, blunt-end ligation reactions were performed using an
oligonucleotide duplex linker consisting of BW-1 (5’
GCGGTGACCCGGGAGATCTGAATTC) and BW-2 (5’ GAATTCAGATC). DNA was ligated
overnight at 16°C in ligation buffer (50mM TrispH7.5, 10mM MgCl2, 10mM
DTT, 1mM ATP) and T4 DNA ligase (Promega). Ligase was inactivated by incubation
for 10 min at 70°C. Ligation reaction was diluted 1:3 in H2O
prior to being used for PCR. Nested PCR was used to detect ligation products
resulting from both Jκ1 and
Jκ2 double stranded DNA breaks. The first round of
amplification was performed using Qiagen Hot Star Taq (1.25U/rxn) and primers
Ko3 (5’ AGTGCCACTAACTGCTGAGAAACCT) and BW-1H (5’
CCGGGAGATCTGAATTCCAC). The PCR reaction was performed as follows: 95°C
for 15min, followed by 26 cycles of 94°C for 45 sec, 57°C for 45
sec and 72°C for 50 sec, followed by 72°C for 5 min. The second
round of amplification was performed as quantitative PCR using primers Ko
(5’ CCACGCATGCTTGGAGAGGGGGTT) and BW-1H primers with an internal Jk
probe (5’ 56-FAM/ZEN-3-Iowa Black 5’ TGAGGAGGGTTTTTGTACAGCCAGA).
Signals were normalized to actin amplified from genomic DNA (Mm00607939_s1).
Each sample was calculated as a percent of a BM standard run on each PCR plate
to determine variability within BM and LP samples from three biologic replicates
isolated from independent pools of 4–8 mice per experiment.
Repertoire Sequencing
Total RNA was obtained from purified B cells using TRIzol reagents
(Invitrogen). κ-chain and μ chain cDNAs from each sample were
synthesized using a SMARTer™-RACE cDNA amplification kit (Clontech),
according to the manufacturer’s protocol.
Cμ-specific (5’-CAGGTGAAGGAAATGGTGCT) and
Cκ-specific (5’-TTAACTGCTCACTGGATGGTG)
primers were used in lieu of oligo dT primers for cDNA synthesis. A total of
0.05 to 0.2 µg total RNA/sample was used. PCR was performed using
Phusion DNA Polymerase (Thermo Scientific) and 12.5 ml of first-strand reactions
with long and short universal primers
(CTAATACGACTCACTATAGGGCAAGCAGTGGTAACAACGCAGAGT and CTAATACGACTCACTATAGGGC)
together with either a biotinylated round-1 Cμ primer (BIO
5’-CTTATCAGACAGGGGGCTCTC) or round-1 Cκ primer
(BIO- 5’-TCACTGGATGGTGGGAAGAT) specific primers. First round PCR
reaction conditions were then followed as described elswhere[29]. PCR round-1 product sizes of
500–700 bp were extracted from agarose gels using a QIAquick gel
extraction kit (Qiagen), enriched on streptavidin-coupled Dynabeads
(Invitrogen), and purified with a QIAquick PCR purification columns (Qiagen) per
manufacturers instructions. Purified round-1 products were then subjected to a
second round of PCR with nested primers containing “A” and
“B” adapter sequences as well as distinct 10 bp barcode
sequences (to distinguish source material) using the nested universal primer
(5’-CGTATCGCCTCCCTCGCGCCATCAG[UNIQUE 10BP BARCODE
SEQUENCE]ACGACTCACTATAGGGCAAGCAG) together with either nested Cμ primer
(CTATGCGCCTTGCCAGCCCGCTCAG[UNIQUE 10BP BARCODE SEQUENCE]GGGAAGACATTTGGGAAGGA) or
Cκ primer (CTATGCGCCTTGCCAGCCCGCTCAG[10 bp UNIQUE
BARCODE SEQUENCE]TGGATGGTGGGAAGATGGAT). PCR products (size 500–700) were
extracted from agarose gel, and 100 ng of each amplicon library was combined and
used for 454 sequencing analysis. GS FLX Titanium sequencing kit XLR70 (Roche)
was used for sample preparation. Data were collected at the sequencing core and
at the University of Illinois. Data were analyzed using the empirical Bayes
procedure as described[30].
Clonotypes and clone assignments were determined using a recursive set of
hypothesis tests on the equality of the V-gene segment mutation rate and that of
CDR3. To control for false detection rate, comparisons were made between the
same tissues of repeat experiments of BM and LP Vκ
samples (Supplementary Fig.
13). V segment usage from
RAG2+ BM was also compared to total splenic B cell
V segment usage to ensure that our analysis
could identify the expected differences that occur due to selection between
these populations.
Statistics
If not otherwise stated, data were expressed as arithmetic means
± s.e.m., and statistical analyses were made by unpaired
t-test, exact test, or χ2 test where
appropriate. P<0.05 was considered statistically
significant.
Authors: Mila Jankovic; Rafael Casellas; Nikos Yannoutsos; Hedda Wardemann; Michel C Nussenzweig Journal: Annu Rev Immunol Date: 2004 Impact factor: 28.527
Authors: John E Butler; Patrick Weber; Marek Sinkora; Diane Baker; Amanda Schoenherr; Balazs Mayer; David Francis Journal: J Immunol Date: 2002-12-15 Impact factor: 5.422
Authors: S V Desiderio; G D Yancopoulos; M Paskind; E Thomas; M A Boss; N Landau; F W Alt; D Baltimore Journal: Nature Date: 1984 Oct 25-31 Impact factor: 49.962
Authors: Jimmy L Zhao; Chao Ma; Ryan M O'Connell; Arnav Mehta; Race DiLoreto; James R Heath; David Baltimore Journal: Cell Stem Cell Date: 2014-02-20 Impact factor: 24.633
Authors: Ashima Shukla; Cindi Chen; Julia Jellusova; Charlotte R Leung; Elaine Kao; Numana Bhat; Wai W Lin; John R Apgar; Robert C Rickert Journal: JCI Insight Date: 2019-07-23
Authors: Yusuke Shono; Melissa D Docampo; Jonathan U Peled; Suelen M Perobelli; Robert R Jenq Journal: Int J Hematol Date: 2015-03-27 Impact factor: 2.490